Immunohistochemical analysis of tumor tissues demonstrated that CIA1 treatment downregulated BGN, Ki67, and p-AKT expression, while NR2F2 and total AKT levels remained unchanged (Figure S8D-E), suggesting that CIA1 primarily acts through inhibition of the NR2F2-BGN axis. The gene discussed is CIAO1; the disease is neoplasm.